Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 172-181

  Bereket, A ^a   Lang, C H ^a   Wilson, T A ^a  

^a NONE

Author keywords

Diabetes; Diabetic complications; IDDM; IGF I treatment; IGFBP; Insulin; Insulin like growth factor binding proteins

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HEMOGLOBIN A1C; HORMONE ANTAGONIST; INSULIN; MESSENGER RNA; OCTREOTIDE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

ARTICLE; CLINICAL TRIAL; FEEDBACK SYSTEM; HORMONE RESISTANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0032899253     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978716     Document Type: Article

References (76)

1. 1. Guest GM. The Mauriac syndrome, dwarfism, hepatomegaly and obesity with juvenile diabetes mellitus. Diabetes 1953; 2: 415-7
2. 2. Tattersall RB, Pyke DA. Growth in diabetic twins. Lancet 1973; 2: 1105-9
3. 3. Salardi S, Tonioli S, Tassoni P, Tellarini M, Manzati L, Cacciari E. Growth and growth factors in diabetes mellitus. Arch Dis Child 1987; 62: 57-62
4. 4. Murata A, Yasuda T, Niimi H. Two cases of with insulin-dependent diabetes mellitus under insulin treatment with slow height velocity. Relationship of growth hormone-binding protein, metabolic control and growth. Acta Paediatr Jpn 1994; 36: 272-5
5. 5. Rudolf MC, Sherwin RS, Markowitz R, Bates SE, Genel M, Hochstadt J, Tamborlane WV. Effect of intensive insulin treatment on linear growth in the young diabetic patient. J Pediatr 1981; 101: 333-9
6. 6. Baxter RC, Brown AS, Turtle JR. Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes. Horm Metab Res 1980; 12: 377-81
7. 7. Maes M, Underwood LE, Ketelslegers JM. Low serum somatomedin-C in insulin-dependent diabetes: Evidence for a postreceptor mechanism. Endocrinol 1986; 118: 377-82
8. 8. Goldstein S, Sertch GJ, Levan KR, Phillips LS. Nutrition and somatomedin. 19. Molecular regulation of insulin-like growth factor I in streptozotocin-diabetic rats. Mol Endocrinol 1988; 2: 1093-1100
9. 9. Schaper NC. Growth hormone secretion in type 1 diabetes: A review. Acta Endocrinol 1990; 122: 7-12
10. 10. Lanes R, Recker B, Fort P, Lifshitz F. Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes 1985; 34: 156-60
11. 11. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press M, Tamborlane W. Effect of diabetes and its control on insulin-like growth factors in the young subject with type 1 diabetes. Diabetes 1984; 33: 1175-9
12. 12. Winter RJ, Phillips LS, Klein MN, Traisman HS, Green OC. Somatomedin activity and diabetic control in children with insulin-dependent diabetes. Diabetes 1979; 28: 952-4
13. 13. Tan K, Baxter RC. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age. J Clin Endocrinol Metab 1986; 63: 651-5
14. 14. Horner JM, Kemp SF, Hintz RL. Growth hormone and somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1981; 53: 1148-53
15. 15. Lamberton RP, Goodman AD, Kassoff A, Rubin CL, Treble DH, Saba TM, Merimee TJ, Dodds WJ. Von Willebrand factor (VII R: Ag), Fibronectin and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes 1984; 33: 125-9
16. 16. Ashton IK, Dornan TL, Pocock AE, Turner RC, Bron AJ. Plasma somatomedin activity and diabetic retinopathy. Clin Endocrinol 1983; 19: 105-110
17. 17. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors: studies in diabetes with and without retinopathy. N Engl J Med 1983; 309: 527-30
18. 18. Blethen SL, Sargeant DT, Whitlow MG, Santiago JV. Effect of pubertal stage and recent blood glucose on plasma somatomedin C in children with insulin-dependent diabetes mellitus. Diabetes 1981; 30: 868-72
19. 19. Salardi S, Cacciari E, Ballardini D, Righetti F, Capelli M, Cicognani A, Zucchini S, Natali G, Tassinari D. Relationships between growth factors (Somatomedin-C and GH) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Diabetes 1986; 35: 832-6
20. 20. Rogers DG, Sherman LD, Gabbay KH. Effect of puberty on insulin-like growth factor I and Hb-A1 in type I diabetes. Diabetes Care 1991; 14: 1031-5
21. 21. Tamborlane WV, Hintz RL, Bergman M, Genel M, Felig P, Sherwin RS. Insulin-infusion-pump treatment of diabetes. Influence of improved metabolic control on plasma somatomedin levels. N Engl J Med 1981; 305: 303-7
22. 22. Hall K, Johansson BL, Povoa G, Thalme B. Serum levels of insulin-like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion. J Int Med 1989; 225: 273-8
23. 23. Merimee TJ, Gardner DF, Zapf J, Froesch ER. Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus. Diabetes 1984; 33: 790-3
24. 24. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA. Effect of insulin on the IGF system in children with new onset insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 1312-7
25. 25. Strasser-Vogel B, Blum WF, Past R, Kessler U, Hoeflich A, Meiler B, Kiess W. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment. J Clin Endocrinol Metab 1995; 80: 1207-13
26. 26. Munoz MT, Barrios V, Pozo J, Argente J. Insulin-like growth factor I, its binding proteins-1, and -3, and growth-hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Pediatr Res 1996; 39: 992-8
27. 27. Acerini CL, Clayton KL, Hintz R, Baker B, Watts A, Holly JM, Dunger DB. Serum insulin-like growth factor II levels in normal adolescents and those with insulin-dependent diabetes mellitus. Clin Endocrinol 1996; 45: 13-9
28. 28. Radetti C, Paganini C, Antoniazzi F, Pasquino B, Valentini R, Gentili L, Tato L. Growth hormone-binding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus. Horm Res 1997; 47: 110-5
29. 29. Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Chale JJ, Rosenfeld R, Tauber JP. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I and IGF-binding protein-3 in IDDM. Diabetologia 1996; 39: 1498-1504
30. 30. Kratzsch J, Keliner K, Zilkens T, Schmidt-Gayk H, Selisko T, Scholz GH. Growth hormone-binding related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus. Clin Endocrinol 1996; 44: 673-8
31. 31. Menon RK, Arslanian S, May B, Cutfield WS, Sperling MA. Diminished GH binding protein in children with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1992; 74: 936-8
32. 32. Mercado M, Molitch ME, Baumann G. Low plasma GH binding protein in IDDM. Diabetes 1992; 41: 605-9
33. 33. Massa G, Dooms L, Bouillon R, Vanderschueren-Lodeweyckx M. Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type-1 (insulin dependent) diabetes mellitus. Diabetologia 1993; 36: 239-43
34. 34. Tapainen P, Kaar M-L, Leppaluoto J, Huttunen N-P, Knip M. Normal stimulated growth hormone secretion but low peripheral levels of insulin-like growth factor I in prepubertal children with insulin-dependent diabetes mellitus. Acta Paediatr 1995; 84: 646-50
35. 35. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R, D'Alessio D. Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1995; 80: 2139-43
36. 36. Cheetham TD, Holly JM, Clayton K, Cwyfan-Hughes S, Dunger DB. The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type-1 diabetes. Diab Med 1995; 12: 885-92
37. 37. Wurzburger MI, Prelevic GM, Sonksen PH, Wheeler M, Balint-Peric L. Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients. Acta Diabetol 1995; 32: 131-4
38. 38. Arslanian SA, Menon RK, Gierl AP, Heil BV, Foley TP. Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type-1 diabetes. Diabet Med 1993; 10: 833-8
39. 39. Guler H-P, Zapf J, Froesch ER. Short term metabolic effects of recombinant human insulin-like growth factor-I in healthy adults. New Engl J Med 1987; 317: 137-40
40. 40. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Experiment Biol Med 1993; 204: 4-29
41. 41. Bar RS, Clemmons DR, Boes M, Busby WH, Booth BA, Dake BL, Sandra A. Transcapillary permeability, and subendothelial distribution of endothelia and amniotic fluid IGF-binding proteins in rat heart. Endocrinology 1990; 127: 1078-86
42. 42. Suikkari A-M, Koivisto VA, Rutanen E-M, Yki-Jarvinen H, Kenonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66: 266-72
43. 43. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991; 73: 964-8
44. 44. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79: 872-8
45. 45. Frost RA, Bereket A, Wilson TA, Wojnar MM, Lang CH, Gelato MC. Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin dependent diabetes mellitus and severe trauma. J Clin Endocrinol Metab 1994; 78: 1533-5
46. 46. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phosphorylation of insulin like growth factor (IGF) binding protein-1 in cell cultures and in vivo: Effects of affinity for IGF-I. Proc Natl Acad Sci USA 1991; 88: 7481-5
47. 47. Lewitt MS, Baxter RC. Insulin-like growth factor-binding protein-1: a role in glucose counterregulation? Mol Cel Endocrinol 1991; 79: C147-52
48. 48. Cotterill AM, Daly F, Holly JMP, Hughes SC, Camacho-Hübner C, Abdulla AF, Gale EAM, Savage M. The dawn phenomenon in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Clin Endocrinol 1995; 43: 567-74
49. 49. Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JAH, Patel S, Tate VE. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol 1990; 32: 229-39
50. 50. Bereket A, Lang CH, Blethen SL, Co Ng L, Wilson TA. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children. Clin Endocrinol 1996; 45: 321-6
51. 51. Ooi GT, Tseng LYH, Rechler MM. Posttranscriptional regulation of insulin-like growth factor binding protein-2 mRNA in diabetic liver. Biochem Biophys Res Com 1992; 189: 1031-7
52. 52. Clemmons DR, Snyder DK, Busby WH. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 1991; 73: 727-33
53. 53. Bereket A, Lang CH, Blethen SL, Wilson TA. Insulin-like growth factor-binding protein-2 and insulin: Studies in children with type-1 diabetes mellitus and maturity-onset diabetes of the young. J Clin Endocrinol Metab 1995; 80: 3647-52
54. 54. Schwander J, Mary JL. The RIA for IGFBP-2 in man - a meagre catch? Growth Regul 1993; 3: 104-8
55. 55. Blum WF, Horn N, Kratzsch J, Jorgensen JO, Juul A, Teale D, Mohnike K, Ranke MB. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 1993; 3: 100-4
56. 56. Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986; 78: 1504-12
57. 57. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. Insulin-like growth factor binding protein-3 proteolysis in children with insulin dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995; 80: 2282-8
58. 58. Bereket A, Wilson TA, Kolasa, Fan J, Lang CH. Regulation of the insulin-like growth factor system by acute acidosis. Endocrinology 1996; 137: 2238-45
59. 59. Binoux M, Lalou C, Lasarre C, Blat C, Hossenlopp P. Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bioavailability. In: Le Roith, D, Raizada MK (eds). Current directions in insulin-like growth factor research. New York Plenum Press 1994: 293-300
60. 60. Bereket A, Wilson TA, Blethen SL, Sakurai Y, Herndon DN, Wolfe RR, Lang CH. Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns. Clin Endocrinol 1996; 44: 525-32
61. 61. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
62. 62. Kohner EM, Hamilton AM, Joplin GF, Fraser TR. Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes 1976; 25: 104-10
63. 63. Merimee TJ. A follow-up study of vascular disease in growth hormone deficient dwarfs with diabetes. N Engl J Med 1978; 298: 1217-22
64. 64. Ledet T, Vuust J. Arterial procollagen type I, type III, and fibronectin. Effects of diabetic serum, glucose, insulin, ketone and growth hormone studied on rabbit aortic myomedial cell cultures. Diabetes 1980; 29: 964-70
65. 65. Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 2809-15
66. 66. Wang Q, Dills DG, Klein R, Klein BE, Moss SE. Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy. Diabetes 1995; 44: 161-4
67. 67. Waldbillig RJ, Jones BE, Schoen TJ, Moshayedi P, Heidersbach S, Bitar MS, van Kuijk FJ, de Juan E, Kador P, Chader GJ. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics in the pathogenesis of diabetic neuropathy. Curr Eye Res 1994; 13: 539-46
68. 68. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier break-down. Diabetes 1997; 46 (2): S26-S30
69. 69. Migdalis IN, Kalogeropoulou K, Kalantzis L, Nounopoulos C, Bouloukos A, Samartzis M. Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabet Med 1995; 12: 823-7
70. 70. Ishii DN. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Rev 1995; 20: 47-67
71. 71. Zhuang HX, Wuarin L, Fei ZJ, Ishii DN. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy. J Pharmacol Exp Ther 1997; 283: 366-74
72. 72. Flyvbjerg A. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int 1997; 52: S12-9
73. 73. Serri O, Beauregard H, Brazeau P, Adribat T, Lambert J, Harris AG, Vachon L. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. J Am Med Ass 1991; 265: 888-92
74. 74. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215-9
75. 75. Carroll PV, Umpleby M, Ward GS, Imuere S, Alexander E, Dunger D, Sonksen PH, Russell-Jones DL. Rh1GF-I administration reduces insulin requirements, decreases growth hormone secretion and improves the lipid profile in adults with IDDM. Diabetes 1997; 46: 1453-8
76. 76. Crowne EC, Samra JS, Cheetham T, Watts A, Holly JM, Dunger DB. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus. Metabolism 1998; 47: 31-8